Nvidia holds a small stake in Nano-X Imaging, which uses AI-based algorithms for Digital Imaging systems to detect early signs of chronic diseases. The company has FDA approval and is expanding its sales, positioning it as an early-stage growth opportunity despite current negative profits.
“one of the smallest stocks here at just $374 million market cap is nano X Imaging ticker innx with Nvidia buying just under 60,000 shares worth $381,000 or about 1% of the company now nox runs its Digital Imaging system with an AI based Suite of algorithms to augment routine CT Imaging helping to find early signs of chronic diseases the company has a current approval with the FDA and is submitted with the EU it's building out its sales and distribution department but this is still a very early stage company with just $110 million in revenue and over the past year and still negative on profits”